Abstract:AIM:To measure in parallel the serum levels and the peripheral blood mononuclear cell (PBMC) mRNA expression of IL-1β, IL-6 and TNF-α both before and after exposure to risperidone during a 4-week treatment protocol for schizophrenia, and to determine whether the levels of these factors were correlated with clinical variables. METHODS: ELISA and reverse transcription-polymerase chain reaction (RT-PCR) techniques were applied to analyze serum levels and PBMC mRNA expression of IL-1β, IL-6 and TNF-α in 83 schizophrenia patients and 65 healthy control subjects. RESULTS: ① Serum IL-1β, IL-6 and TNF-α levels in the schizophrenia group both pre- and post-treatment with risperidone were significantly higher than those in the control subjects (P<0.05). Serum IL-1β levels of the schizophrenia patients decreased significantly after 4-week treatment (P<0.05). ② Serum TNF-α levels of the negative subtype patients were significantly higher than those of the positive subtype patients before treatment (P<0.05). Serum IL-1β of the schizophrenia group and TNF-α levels of the negative subtype patients decreased significantly after 4-week treatment (P<0.05). Serum IL-6 levels of the familial schizophrenia were significantly higher than those of the sporadic schizophrenia before treatment (P<0.05). Serum IL-1β levels of the schizophrenia group and serum TNF-α levels of the familial schizophrenia decreased significantly after 4-week treatment (P<0.05). ③ There was significant correlation between the levels of TNF-α and the severity of negative symptom clusters evaluated by the PANSS (r=0.412, P<0.05). There was significant correlation between the difference of serum IL-1β levels pre- and post- treatment and the rate of the decreased PANSS (r=0.368, P<0.05). ④ IL-1β, IL-6 and TNF-α mRNA expression in the PBMC from the schizophrenia group both pre- and post-treatment were significantly higher than those from the control subjects (P<0.05). IL-1β mRNA expression in the PBMC from the schizophrenia patients decreased significantly after 4-week treatment (P<0.05). CONCLUSION: ① Schizophrenia patients are in a state of immune activation. The difference of serum IL-1β level between pre- and post-treatment with neuroleptic may be a sensitive parameter of illness recovery. ② Changes in the immune system are involved in the pathophy-siology of schizophrenia. ③ PBMC of schizophrenia patient is activated and may be one of major sources of cytokines.

Exploring the mRNA expression level of RELN in peripheral blood of schizophrenia patients before and after antipsychotic treatment

DNA methylation levels of RELN promoter region in ultra-high risk, first episode and chronic schizophrenia cohorts of schizophrenia

Schizophrenia risk candidate EGR3 is a novel transcriptional regulator of RELN and regulates neurite outgrowth via the Reelin signal pathway in vitro

COMT, 5-HTR2A, and SLC6A4 Mrna Expressions in First-Episode Antipsychotic-Naïve Schizophrenia and Association with Treatment Outcomes

Epigenetic Clock Analysis of Blood Samples in Drug-Naive First-Episode Schizophrenia Patients.

Expressional changes of neuregulin-1 gene mRNA in peripheral blood from schizophrenia patients]

Association Study of RELN Polymorphisms with Schizophrenia in Han Chinese Population

[Methylation of the Reelin Gene Promoter in Peripheral Blood and Its Relationship with the Cognitive Function of Schizophrenia Patients]

A New Single-Nucleotide Mutation (rs362719) of the Reelin (RELN) Gene Associated with Schizophrenia in Female Chinese Han.

Altered expression of the CSMD1 gene in the peripheral blood of schizophrenia patients

Association Study of the Reelin (RELN) Gene with Chinese Va Schizophrenia

Meta-analyses of RELN variants in neuropsychiatric disorders

Explorative study on the expression of neuregulin-1 gene in peripheral blood of schizophrenia.

Expression of retinoic acid receptor γ mRNA in blood leukocytes of acute schizophrenic patients

Identification of Reln Variation P.Thr3192ser in A Chinese Family with Schizophrenia

Short-term Effects of Risperidone Monotherapy on Spontaneous Brain Activity in First-episode Treatment-naïve Schizophrenia Patients: A Longitudinal Fmri Study

Serum protein and PBMC mRNA expressions of IL-1β, IL-6 and TNF-α in first-episode schizophrenia

Association Between RELN Polymorphisms and Schizophrenia in a Han Population from Northeast China

Dysregulated 14-3-3 Family in Peripheral Blood Leukocytes of Patients with Schizophrenia

Two Novel Loci of RELN Associated with Antipsychotics Response in Chinese Han Population

SNP Variation of RELN Gene and Schizophrenia in a Chinese Population: A Hospital-Based Case–Control Study